We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+3.18%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$3.21B
AUM Growth
+$635M
(+25%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
4.38%
Top 10 Holdings %
Top 10 Hldgs %
61.08%
Holding
2,133
New
24
Increased
277
Reduced
135
Closed
1,656
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$11M |
| 2 |
RTX Corp
RTX
|
+$9.04M |
| 3 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$8.71M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.77M |
| 5 |
BSCK
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
|
+$5.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$12.4M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$12.2M |
| 3 |
Amgen
AMGN
|
+$8.02M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$7.87M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$4.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.64% |
| 2 | Consumer Discretionary | 7.21% |
| 3 | Financials | 3.14% |
| 4 | Healthcare | 3.07% |
| 5 | Industrials | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vanguard Dividend Appreciation ETF
VIG
$111B
| $15.2M | 0.47% |
132,247
+48,365
| +58% | +$5.42M |
|
27
Bristol-Myers Squibb
BMY
$133B
| $15.2M | 0.47% |
334,342
+28,483
| +9% | +$1.33M |
|
|
28
iShares MSCI ACWI ETF
ACWI
$32.9B
| $15M | 0.47% |
203,650
-166,930
| -45% | -$12.2M |
|
29
Leidos
LDOS
$14.5B
| $14.6M | 0.46% |
183,346
+36,252
| +25% | +$2.65M |
|
30
iShares Core MSCI EAFE ETF
IEFA
$190B
| $13.8M | 0.43% |
225,154
+29,149
| +15% | +$1.79M |
|
31
Comcast
CMCSA
$85B
| $13.8M | 0.43% |
325,509
+67,120
| +26% | +$2.83M |
|
32
CDW
CDW
$18.9B
| $13.6M | 0.42% |
122,682
+25,111
| +26% | +$2.63M |
|
33
Oracle
ORCL
$374B
| $13.6M | 0.42% |
238,748
+51,026
| +27% | +$2.76M |
|
34
Canadian Pacific Kansas City
CP
$78.1B
| $13M | 0.4% |
275,855
+49,680
| +22% | +$2.22M |
|
35
eBay
EBAY
$50.6B
| $12.8M | 0.4% |
324,491
+62,440
| +24% | +$2.35M |
|
36
Merck
MRK
$322B
| $12.8M | 0.4% |
159,229
+9,228
| +6% | +$707K |
|
37
Omnicom Group
OMC
$21.6B
| $12.5M | 0.39% |
152,262
+34,376
| +29% | +$2.71M |
|
38
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $12.4M | 0.38% |
488,870
+109,102
| +29% | +$2.74M |
|
39
PACCAR
PCAR
$69.8B
| $12.1M | 0.38% |
254,169
+54,982
| +28% | +$2.55M |
|
40
Sysco
SYY
$40.8B
| $12.1M | 0.38% |
171,479
+36,186
| +27% | +$2.58M |
|
41
Eli Lilly
LLY
$1.02T
| $11.9M | 0.37% |
107,728
-9,814
| -8% | -$1.16M |
|
42
Lam Research
LRCX
$367B
| $11.9M | 0.37% |
631,380
+135,890
| +27% | +$2.58M |
|
43
Invesco
IVZ
$13.1B
| $11.8M | 0.37% |
576,606
+119,481
| +26% | +$2.48M |
|
44
Reinsurance Group of America
RGA
$15.5B
| $11.7M | 0.36% |
74,835
+16,293
| +28% | +$2.44M |
|
45
Capital One
COF
$128B
| $11.4M | 0.35% |
125,252
+27,928
| +29% | +$2.5M |
|
46
AbbVie
ABBV
$443B
| $11.1M | 0.35% |
153,048
+30,896
| +25% | +$2.43M |
|
47
CenterPoint Energy
CNP
$27.7B
| $10.9M | 0.34% |
380,714
+83,510
| +28% | +$2.49M |
|
|
HDS
48
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.9M | 0.34% |
270,288
+62,111
| +30% | +$2.66M |
|
|
CMA
49
DELISTED
Comerica
CMA
| $10.9M | 0.34% |
149,837
+148,046
| +8,266% | +$11M |
|
50
Encompass Health
EHC
$11B
| $10.9M | 0.34% |
215,244
+62,613
| +41% | +$3.04M |
|
Similar funds
SAM
CHP
FAM
OAG
BA
Cresset Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Cresset Asset Management held 2,133 positions worth $3.21B, up 25% from $2.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Cresset Asset Management deployed $141M of net new capital in Q2 2019, opening 24 new positions and adding to 277 existing holdings. Its largest new stake was CorMedix: 329,796 shares worth $2.96M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $12.4M trimmed.
- Cresset Asset Management's largest Q2 2019 buy was CorMedix: 329,796 shares worth $2.96M.
- Cresset Asset Management added most to Comerica in Q2 2019, an estimated $11M increase.
- Cresset Asset Management's biggest Q2 2019 reduction was Apple, cutting an estimated $12.4M.
- Cresset Asset Management fully exited Global X MLP & Energy Infrastructure ETF in Q2 2019, selling an estimated $3.5M.
- Cresset Asset Management's ten largest holdings make up 61% of its $3.21B portfolio in Q2 2019.
- Cresset Asset Management opened 24 new positions and closed 1,656 in Q2 2019.
- Cresset Asset Management's portfolio value rose 25% quarter-over-quarter to $3.21B.
Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.